RxDoctor Payments Data

Rohan Desai, MD

Orthopaedic Surgery of the Spine · Westbury, NYNPI 1659803583

Payments from drug & device makers

What this record shows

The money is spread across several categories — grants (59.7%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. Globus Medical accounts for 62.0% of it on its own, with 13 other manufacturers making up the rest. Reporting peaked in 2022 at $21,787 and has fallen 63.2% since, to $8,022 in 2025.

$33,456in general payments, 2019–2025

Across 66 payments — averaging $506.90 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Globus Medical$21K
  • Nexxt Spine LLC$7K
  • Integra Lifesciences Corporation$2K
  • Stryker$1K
  • Medtronic$966
  • VB Spine LLC$382
  • plus $1K from 8 others

What the payments were for

  • Consulting fees$2,9259%
  • Grants$19,98260%
  • Travel & lodging$5,15115%
  • Food & beverage$5,39716%

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$33,456 in reported general payments places this provider in the 65th percentile of 161 orthopaedic surgery of the spine providers in New York.

See all orthopaedic surgery of the spine providers in New York

Medicare billing

Part B allowed, 2024
$73,002
Medicare patients
122
Services billed
1,092

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Meloxicam19$24

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery of the spine in Westbury

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →